DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
出版年份 2015 全文链接
标题
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
作者
关键词
-
出版物
CNS Neuroscience & Therapeutics
Volume 21, Issue 7, Pages 549-557
出版商
Wiley
发表日期
2015-05-26
DOI
10.1111/cns.12404
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
- (2014) Konrad Talbot et al. Alzheimers & Dementia
- AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes
- (2014) Magali Balteau et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease
- (2014) Jayasankar Kosaraju et al. BEHAVIOURAL BRAIN RESEARCH
- Brain metabolic dysfunction at the core of Alzheimer's disease
- (2014) Suzanne M. de la Monte et al. BIOCHEMICAL PHARMACOLOGY
- Mitochondrial import and degradation of amyloid-β peptide
- (2014) Catarina Moreira Pinho et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
- (2014) D. Allan Butterfield et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
- (2014) F. G. De Felice et al. DIABETES
- Insulin Action in Brain Regulates Systemic Metabolism and Brain Function
- (2014) A. Kleinridders et al. DIABETES
- Liraglutide Enhances Insulin Sensitivity by Activating AMP-Activated Protein Kinase in Male Wistar Rats
- (2014) Satoru Yamazaki et al. ENDOCRINOLOGY
- Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
- (2014) Lindsay J. Spielman et al. JOURNAL OF NEUROIMMUNOLOGY
- Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship
- (2013) N. T. Vagelatos et al. EPIDEMIOLOGIC REVIEWS
- Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
- (2013) Barbara Fruci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AMPK, insulin resistance, and the metabolic syndrome
- (2013) Neil B. Ruderman et al. JOURNAL OF CLINICAL INVESTIGATION
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. NEUROPHARMACOLOGY
- Adrenergic signaling and oxidative stress: a role for sirtuins?
- (2013) Graziamaria Corbi et al. Frontiers in Physiology
- SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
- (2013) Munehiro Kitada et al. Diabetes & Metabolism Journal
- Amyloid β-Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
- (2012) D. Allan Butterfield et al. ANTIOXIDANTS & REDOX SIGNALING
- Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
- (2012) Christian Hölscher CNS DRUGS
- The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
- (2012) V. Darsalia et al. DIABETES
- Linagliptin
- (2012) Emma D. Deeks DRUGS
- Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-β at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3β Signaling Pathway
- (2012) Takayoshi Tokutake et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β Protein Modulates Insulin Signaling in Presynaptic Terminals
- (2012) David Heras-Sandoval et al. NEUROCHEMICAL RESEARCH
- SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer’s Disease
- (2012) Tatiane Katsue Furuya et al. NEUROCHEMISTRY INTERNATIONAL
- Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
- (2012) Matthias Kern et al. PLoS One
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Truncated tau and Aβ cooperatively impair mitochondria in primary neurons
- (2011) Rodrigo A. Quintanilla et al. NEUROBIOLOGY OF AGING
- Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms
- (2010) S. V. de Kreutzenberg et al. DIABETES
- Tissue distribution of the novel DPP-4 inhibitor BI 1356 is dominated by saturable binding to its target in rats
- (2009) Holger Fuchs et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications
- (2008) Karen Neumann et al. Current Alzheimer Research
- (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors
- (2008) L. Thomas et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started